FP
OGN icon

Foundry Partners’s Organon & Co OGN Stock Holding History

Foundry Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.5M Sell
302,319
-108,138
-26% -$1.66M 0.24% 137
2024
Q4 		$6.12M Buy
410,457
+10,963
+3% +$179K 0.31% 101
2024
Q3 		$7.64M Buy
+399,494
New +$8.28M 0.38% 76

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Foundry Partners's OGN Position: Q1 2025 in Review

Foundry Partners reduced its Organon & Co (OGN) stake by 26% in Q1 2025, selling an estimated $1.66M and leaving 302,319 shares worth $4.5M. The position accounts for 0.24% of the portfolio, ranked #137.

Foundry Partners first reported a position in OGN in Q3 2024 and has held it in 3 quarters since. The position peaked at $7.64M in Q3 2024. 719 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Foundry Partners held 302,319 shares of Organon & Co worth $4.5M as of Q1 2025.
  • Foundry Partners sold 108,138 Organon & Co shares in Q1 2025, an estimated $1.66M.
  • Organon & Co made up 0.24% of Foundry Partners's portfolio in Q1 2025, its #137 holding.
  • Foundry Partners first reported a position in Organon & Co in Q3 2024 and has held it in 3 quarters since.
  • Foundry Partners's Organon & Co position peaked at $7.64M in Q3 2024.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Foundry Partners's 13F filing for Q1 2025, filed 5 May 2025.